GlassScriptPhysician profile
Shanda R Hofmann
NPI 1811660822
$10,737.79
in general payments reported to CMS, 2019-2025
39 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $406 · 2022: $3,375 · 2023: $3,457 · 2024: $3,282 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,940 · Consulting Fee: $17.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,940.32 |
| Consulting Fee | $17.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,857.92 | 2021-2025 | Jardiance, Ofev |
| Astrazeneca Pharmaceuticals LP | $1,013.45 | 2022-2024 | Farxiga, Airsupra, Wainua |
| Pfizer INC. | $847.57 | 2022-2024 | |
| Amgen INC. | $819.46 | 2021-2024 | Repatha, Otezla, Krystexxa |
| Esperion Therapeutics, INC. | $708.91 | 2022-2024 | Nexletol, Nexlizet |
| Merck Sharp & Dohme LLC | $597.31 | 2021-2024 | Verquvo, Belsomra, Steglatro |
| Lilly USA, LLC | $501.22 | 2022-2024 | Jardiance, Zepbound |
| Abbvie INC. | $479.62 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $472.53 | 2021-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $447.61 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $445.94 | 2022-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $420.73 | 2022-2024 | Wegovy, Ozempic, Rybelsus |
| Amarin Pharma, INC. | $293.69 | 2021-2023 | |
| Glaxosmithkline, LLC. | $291.62 | 2022-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Novartis Pharmaceuticals Corporation | $220.06 | 2023-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $172.83 | 2021-2022 | |
| Exact Sciences Corporation | $132.38 | 2023-2024 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $125.70 | 2022 | |
| Heartflow, INC. | $88.47 | 2024-2025 | |
| Scpharmaceuticals INC. | $80.46 | 2023-2024 | |
| Irhythm Technologies, INC. | $74.93 | 2022 | |
| Inspire Medical Systems, INC. | $62.33 | 2024 | Inspire |
| Cvrx, INC. | $61.60 | 2023 | Barostim Neo System |
| Scilex Pharmaceuticals INC. | $54.91 | 2023-2024 | Ztlido |
| Atricure, INC. | $52.60 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.65 | 2023-2024 | Xifaxan |
| Kiniksa Pharmaceuticals International, Plc | $51.21 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $49.38 | 2022 | |
| Medtronic, INC. | $41.40 | 2024 | Corevalve Evolut R |
| Kiniksa Pharmaceuticals, LTD. | $33.81 | 2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $30.34 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.48 | 2022-2024 | Lifevest |
| Viiv Healthcare Company | $21.88 | 2023 | Apretude |
| Ardelyx, INC. | $21.35 | 2024 | Ibsrela |
| Alnylam Pharmaceuticals INC. | $20.07 | 2024 | Onpattro |
| Ironwood Pharmaceuticals, INC | $19.16 | 2024 | |
| Baxter Healthcare | $17.00 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Phadia US INC. | $15.94 | 2022 | |
| Dexcom, INC. | $13.27 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shanda Hofmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.